This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Actavis Group Ptc Ehf. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Venkata Sasidhar Balla: Innovator in Pharmaceutical Processes
Introduction
Venkata Sasidhar Balla is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that enhance the production of important drug intermediates. His work is characterized by a focus on improving yield and purity in pharmaceutical manufacturing.
Latest Patents
Venkata Sasidhar Balla holds a patent for a process titled "Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide." This patent describes an improved, commercially viable, and industrially advantageous method for preparing the Repaglinide intermediate. The process is designed to provide the intermediate in higher yield and purity compared to previously disclosed methods, facilitating the production of Repaglinide and its pharmaceutically acceptable salts.
Career Highlights
Venkata Sasidhar Balla is associated with Actavis Group Ptc Ehf, where he applies his expertise in pharmaceutical processes. His innovative approach has led to advancements in the efficiency of drug production, making significant impacts in the pharmaceutical industry.
Collaborations
Throughout his career, Venkata has collaborated with talented professionals, including Madhubabu Alapharthi and Nitin Sharadchandra Pradhan. These collaborations have contributed to the successful development of his patented processes.
Conclusion
Venkata Sasidhar Balla is a distinguished inventor whose work in pharmaceutical processes has led to significant advancements in drug production. His innovative methods enhance the efficiency and quality of important pharmaceutical intermediates, making a lasting impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile